Table 1 |
|||||
|
Summary of aging-related diseases affected by caloric restriction in experimental animal models and clinical trialsa |
|||||
|
Diseases |
Findings |
Rodents |
Nonhuman primates |
Humans |
References |
|
|
|||||
|
Cancer |
CR prevents a broad range of cancer incidences, including breast and gastrointestinal cancer. |
Y |
Y |
Y/? |
|
|
Diabetes |
CR improves glucose homeostasis and prevents diabetes. |
Y |
Y |
Y |
|
|
Cardiovascular diseases |
CR lowers blood pressure and favorably alters lipid profile, resulting in significantly reducing the risk of cardiovascular disease and related complications. |
Y |
Y |
Y |
|
|
Neurodegenerative diseases |
CR reduces aging-associated neuronal loss and neurodegenerative disorders such as Parkinson's disease and Alzheimer's disease. |
Y |
Y |
Y/? |
|
|
Immune deficiencies |
CR delays the onset of T-lymphocyte-dependent autoimmune diseases. |
Y |
Y/? |
Y/? |
[21] |
|
|
|||||
|
aCR, caloric restriction; Y, CR has effects on relevant physiological changes; Y/?, not resolved or not reported. |
|||||
|
Li et al. BMC Medicine 2011 9:98 doi:10.1186/1741-7015-9-98 |
|||||